- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
Abbott Labs' shares fell nearly 1% in premarket trading after the company reported mixed earnings results.
The Federal Trade Commission says Abbott Laboratories can proceed with its proposed $25 billion acquisition of St. Jude Medical.
Abbott can now proceed with its $25 billion buy of St. Jude Medical.